IXC ASX News

15 December 2024

Improved Neuronal Cell Survival in 3D Model of Alzheimer's

Exenatide improves neuronal survival in Alzheimer's model, showing potential for AD treatment.

Invex Therapeutics Exenatide Alzheimer's Disease Biopharmaceuticals Stock Market News

Posted on: 15/12/2024

Read More

23 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Invex Therapeutics updates on clinical trials, financials, and corporate developments.

Invex Therapeutics Clinical Trials Biopharmaceuticals Stock Market News

Posted on: 23/07/2024

Read More